Skip to content
Menu

Dillard's, Inc. DDS

Full chart Compare
Set alert

Price alert · DDS

All alert types
551.46 USD -7.83 (-1.40%)

Regular-session close

550.05 -1.41 -0.26%

After hours · Nov 20, 4:00 PM ET

548.62 Day range 573.76
510.39 52-week range 730.73
YTD
-9.05%
1 year
-7.56%

Fundamental scorecard

20 of 25 checks passed on DDS’s reported financials

ValueGrowthProfitabilityHealthDividend

20of 25 checks passed

  • Value 3 of 5
  • Growth 4 of 5
  • Profitability 4 of 5
  • Financial health 5 of 5
  • Dividend 4 of 5

Statements to Aug 1, 2026.

Value 3 of 5

  • Failed:P/E below its own 5-year median P/E 12.6 against a 5-year median of 8.6.
  • Passed:P/E under 20 P/E 12.6: an earnings yield of 7.9%.
  • Failed:Price to sales below its own 5-year median Price to sales 1.3 against a 5-year median of 0.9.
  • Passed:Price to book below its own 5-year median Price to book 4.1 against a 5-year median of 4.1.
  • Passed:Free cash flow yield above 4% Free cash flow of 655M is 7.6% of the market value.

Growth 4 of 5

  • Passed:Revenue grew over the last year Revenue of 6.60B is +0.2% on the 12 months before.
  • Passed:Revenue grew more than 5% a year over five years +8.2% a year from FY 2021 to FY 2026.
  • Passed:Earnings per share grew over the last year EPS 43.63 against 36.18 in the 12 months before.
  • Passed:Earnings per share grew more than 5% a year over five years EPS -3.16 in FY 2021, 36.42 in FY 2026.
  • Failed:Analysts expect higher earnings per share over the next year The average forward estimate is -20.9% on the last 12 months.

Profitability 4 of 5

  • Passed:Profitable over the last year Net income of 682M over the last 12 months.
  • Passed:Profitable in each of the last five fiscal years A profit in 5 of the last 5 fiscal years.
  • Passed:Return on equity above 15% Return on equity of 33.8%.
  • Failed:Net margin above its 5-year average Net margin of 10.3% against a 5-year average of 10.8%.
  • Passed:Free cash flow is at least 80% of net income Free cash flow of 655M is 96.1% of net income.

Financial health 5 of 5

  • Passed:Short-term assets cover short-term liabilities Short-term assets of 2.68B against short-term liabilities of 884M.
  • Passed:Short-term assets cover long-term liabilities Short-term assets of 2.68B against long-term liabilities of 745M.
  • Passed:Net debt under 40% of equity More cash than debt: 1.26B of cash against 457M of debt.
  • Passed:Operating cash flow covers at least 20% of debt Operating cash flow of 724M is 158.6% of debt.
  • Passed:Operating profit covers interest at least 3 times No interest expense reported.

Dividend 4 of 5

  • Passed:Pays a dividend 486M paid over the last 12 months.
  • Passed:Yield above 1.5% A yield of 5.6% at the current market value.
  • Passed:Pays out under 75% of profit 71.3% of net income is paid out.
  • Passed:Covered by free cash flow 74.2% of free cash flow is paid out.
  • Failed:Not cut in the last five fiscal years The total paid fell in 1 of the last five fiscal years.

Mechanical checks on reported financials against fixed thresholds. They describe the numbers; they are not a recommendation to buy or sell.

Included in Essentials and up

Sign in to see Fair value

Discounted cash flow estimates against the price, and the P/E against its industry and sector.

Included in Essentials and up

Sign in to see Head count and owner earnings

Employees by annual report and the cash the business earns for its owners.

Included in Essentials and up

Sign in to see P/E against peers

The price to earnings ratio beside the closest competitors and their median.

Financial position

What DDS owns and owes, as of Aug 1, 2026

Short term and long term

Balance sheet · 3.75B of assets

Debt, equity and cash by year

Now: 804M more cash than debt

Fiscal years, then the newest quarter. Cash includes short-term investments.

From the company’s SEC filings.

Included in Essentials and up

Sign in to see Cash flow and returns

How profit turns into free cash flow, and the returns on equity, assets and capital.

Financial health

Altman Z-Score

8.36 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

A4 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 4
  • P/E 3
  • P/B 2

Valuation

P/E 16.7×
P/S 1.4×
P/B 5.3×
P/FCF 15.2×
EV/EBITDA 10.5×
EV/Sales 1.4×
FCF Yield 6.6%

Profitability

Gross Margin 37.6%
Operating Margin 10.5%
Net Margin 8.7%
ROE 32.1%
ROIC 20.9%
ROA 16.3%

Growth (YoY)

Revenue -0.4%
Operating Income -7.0%
EPS (diluted) -1.0%
Free Cash Flow 2.3%

Financial Health

Current Ratio 2.6×
Quick Ratio 1.3×
Debt / Equity 0.3×
Net Debt / EBITDA -0.3×
Interest Coverage 0.0×

Dividends

Dividend Yield 5.1%
Payout Ratio 85.0%

Annual · latest fiscal year ends 2026-01-31